Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kewaunee Scientific (KEQU) Enterprise Value (2016 - 2026)

Kewaunee Scientific has reported Enterprise Value over the past 17 years, most recently at -$341000.0 for Q1 2026.

  • Quarterly results put Enterprise Value at -$341000.0 for Q1 2026, up 95.81% from a year ago — trailing twelve months through Jan 2026 was -$341000.0 (up 95.81% YoY), and the annual figure for FY2025 was -$434000.0, up 64.48%.
  • Enterprise Value for Q1 2026 was -$341000.0 at Kewaunee Scientific, up from -$10.7 million in the prior quarter.
  • Over the last five years, Enterprise Value for KEQU hit a ceiling of $839000.0 in Q3 2025 and a floor of -$13.9 million in Q3 2022.
  • Median Enterprise Value over the past 5 years was -$4.4 million (2023), compared with a mean of -$4.8 million.
  • Biggest five-year swings in Enterprise Value: crashed 6831.5% in 2022 and later skyrocketed 106.64% in 2024.
  • Kewaunee Scientific's Enterprise Value stood at -$8.8 million in 2022, then plummeted by 40.9% to -$12.4 million in 2023, then surged by 80.9% to -$2.4 million in 2024, then tumbled by 352.32% to -$10.7 million in 2025, then soared by 96.82% to -$341000.0 in 2026.
  • The last three reported values for Enterprise Value were -$341000.0 (Q1 2026), -$10.7 million (Q4 2025), and $839000.0 (Q3 2025) per Business Quant data.